Bowen Acquisition Corp
Status: Live Deal
U=S+R
R=S/10
IPO Proceeds, $M | $69.00M |
---|---|
IPO Date | Jul 12, 2023 |
CEO | Jiangang Luo |
Left Lead | EarlyBirdCapital |
IPO Cash in Trust | 101.0% |
SPAC Tenor | 15 + 3 + 4 + 3 |
IPO Sector | General ▶ |
IPO Geography | Asia |
Target Company | Qianzhi BioTech |
Deal Announced | Jan 18, 2024 |
Deal Size, $M | TBD |
Deal Sector | Healthcare |
Deal Geography | Asia |
SEC Filings |
www.sec.gov |
Approval Vote | Jan 14, 2025 |
Amendment Vote | Apr 14, 2025 |
BOWN
BOWNU
BOWNR
Price | $9.50 |
---|---|
Last closing price | $10.00 |
H/L, today | $9.04 / $9.77 |
H/L, 52-week | $10.10 / $10.31 |
Volume, today | 12,466 |
Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.